Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Nanosonics Limited

NNCSFPNK
Healthcare
Medical - Instruments & Supplies
$2.19
$0.00(0.00%)
U.S. Market opens in 1h 37m

Nanosonics Limited Fundamental Analysis

Nanosonics Limited (NNCSF) shows weak financial fundamentals with a PE ratio of 46.24, profit margin of 9.91%, and ROE of 9.57%. The company generates $0.2B in annual revenue with strong year-over-year growth of 15.95%.

Key Strengths

Cash Position24.01%
PEG Ratio-55.19
Current Ratio6.38

Areas of Concern

ROE9.57%
Operating Margin8.95%
We analyze NNCSF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 62.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
62.6/100

We analyze NNCSF's fundamental strength across five key dimensions:

Efficiency Score

Weak

NNCSF struggles to generate sufficient returns from assets.

ROA > 10%
7.36%

Valuation Score

Moderate

NNCSF shows balanced valuation metrics.

PE < 25
46.24
PEG Ratio < 2
-55.19

Growth Score

Excellent

NNCSF delivers strong and consistent growth momentum.

Revenue Growth > 5%
15.95%
EPS Growth > 10%
62.38%

Financial Health Score

Excellent

NNCSF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.04
Current Ratio > 1
6.38

Profitability Score

Weak

NNCSF struggles to sustain strong margins.

ROE > 15%
9.57%
Net Margin ≥ 15%
9.91%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is NNCSF Expensive or Cheap?

P/E Ratio

NNCSF trades at 46.24 times earnings. This suggests a premium valuation.

46.24

PEG Ratio

When adjusting for growth, NNCSF's PEG of -55.19 indicates potential undervaluation.

-55.19

Price to Book

The market values Nanosonics Limited at 4.33 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.33

EV/EBITDA

Enterprise value stands at 37.81 times EBITDA. This signals the market has high growth expectations.

37.81

How Well Does NNCSF Make Money?

Net Profit Margin

For every $100 in sales, Nanosonics Limited keeps $9.91 as profit after all expenses.

9.91%

Operating Margin

Core operations generate 8.95 in profit for every $100 in revenue, before interest and taxes.

8.95%

ROE

Management delivers $9.57 in profit for every $100 of shareholder equity.

9.57%

ROA

Nanosonics Limited generates $7.36 in profit for every $100 in assets, demonstrating efficient asset deployment.

7.36%

Following the Money - Real Cash Generation

Operating Cash Flow

Nanosonics Limited produces operating cash flow of $29.35M, showing steady but balanced cash generation.

$29.35M

Free Cash Flow

Nanosonics Limited generates strong free cash flow of $24.34M, providing ample flexibility for dividends, buybacks, or growth.

$24.34M

FCF Per Share

Each share generates $0.08 in free cash annually.

$0.08

FCF Yield

NNCSF converts 2.57% of its market value into free cash.

2.57%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

46.24

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-55.19

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.33

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.58

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

6.38

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.10

vs 25 benchmark

ROA

Return on assets percentage

0.07

vs 25 benchmark

ROCE

Return on capital employed

0.08

vs 25 benchmark

How NNCSF Stacks Against Its Sector Peers

MetricNNCSF ValueSector AveragePerformance
P/E Ratio46.2428.25 Worse (Expensive)
ROE9.57%780.00% Weak
Net Margin9.91%-20122.00% (disorted) Weak
Debt/Equity0.040.30 Strong (Low Leverage)
Current Ratio6.384.66 Strong Liquidity
ROA7.36%-14687.00% (disorted) Weak

NNCSF outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Nanosonics Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

98.16%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

101.93%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

91.28%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ